Platform for Screening Compounds for Treatment of AMD Using iPSC-derived human RPE: Examples Using Elamipretide and SBT-272

Related

• 

  Vitreoretinal Interface Disease In the Setting of AMD

  Andrew A. Moshfeghi, MD, MBA, FASRS

  Updates from the Field

  2019

• 

  Expert Panel: Pegcetacoplan Safety

  Andre J. Witkin, MD

  David A. Eichenbaum, MD, FASRS

  Samuel Anthony Minaker, MD, MSc

  Janani Singaravelu, MS, MD

  Sunir J. Garg, MD, FACS, FASRS

  Annual Meeting Talks

  2024

• 

  Quality of Life and Retinal Disease During the COVID-19 Pandemic

  Peter Y Zhao, MD

  Annual Meeting Talks

  2021